Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05386238
Other study ID # 18013105-IRB01
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date August 31, 2022
Est. completion date November 15, 2023

Study information

Verified date January 2024
Source Rush University Medical Center
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Objectives*: Primary Objective: Aim 1: Examine the acceptability of tailored behavioral weight loss program and a standard program in men working in blue-collar occupations. Aim 2: Compare recruitment approaches that vary on trust-based messaging to recruit men with overweight/obesity who work in blue-collar occupations. Secondary Objectives: Determine the feasibility of retaining participants to a randomized trial over six months.


Description:

Men working in blue-collar occupations have a high prevalence of overweight and obesity and have high rates of comorbidities associated with obesity. Unfortunately, these men are unlikely to participate in evidenced-based weight loss interventions. Further, few efficacious interventions have been developed that target this population for weight control. The purpose of this study is to test the feasibility and acceptability of tailored recruitment messages and a novel, tailored behavioral weight loss intervention in the context of a randomized trial.


Recruitment information / eligibility

Status Completed
Enrollment 28
Est. completion date November 15, 2023
Est. primary completion date November 15, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 18 Years and older
Eligibility Inclusion criteria: 1. Age 18 years and older 2. Male 3. Body mass index (BMI) > 25 kg/m2 4. Employed >20 hours per week in an occupation classified as blue collar 5. Ability to communicate in English 6. Provision of signed and dated informed consent form Exclusion criteria: 1. History of bariatric surgery 2. Diabetes managed with insulin 3. Diagnosis of a serious mental illness 4. Conditions contraindicated to exercise independently (determined using four questions of Physical Activity Readiness Questionnaire) 5. Report of potentially hazardous alcohol use (ASSIST >27) 6. Weight loss in the prior six months of 10 pounds or greater 7. Body mass index =60 kg/m2, due to increased injury risk with exercise 8. Diagnosis of an eating disorder 9. Any major medical condition that could increase risk for injury or other contradictions for treatment, or high likelihood of attrition, as determined by the study team

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Standard behavioral weight loss program
16 internet-delivered, group sessions over 6 months supported by digital handouts. The intervention will focus on changes to eating, physical activity, and self-monitoring.
Tailored behavioral weight loss program
16 internet-delivered, group sessions over 6 months supported by digital handouts or videos tailored to men working in blue-collar occupations. The intervention will focus on changes to eating, physical activity, and self-monitoring.

Locations

Country Name City State
United States Rush University Medical Center Chicago Illinois

Sponsors (1)

Lead Sponsor Collaborator
Rush University Medical Center

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other Clinically significant weight loss Proportion of participants who achieve a weight loss >5% of initial weight Baseline, 3, and 6 months
Other Program perceptions Semi-structured interviews to evaluate participants perceptions of program 3 and 6 months
Primary Participant satisfaction with the intervention Acceptability of the intervention will be reported as participants satisfaction with the program rated on a 7 point scale 3 months
Primary Recruitment response Proportion of participants who enroll in study by recruitment message type Baseline
Secondary Retention rates for each intervention group Proportion of participants who complete the final follow up assessment 6 months
Secondary Recruitment reach Number of visits to study websites Baseline
Secondary Participant satisfaction with the intervention Acceptability of the intervention will be reported as participants satisfaction with the program rated on a 7 point scale 6 months
See also
  Status Clinical Trial Phase
Recruiting NCT04243317 - Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults N/A
Recruiting NCT04101669 - EndoBarrier System Pivotal Trial(Rev E v2) N/A
Terminated NCT03772886 - Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball N/A
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Completed NCT04506996 - Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2 N/A
Recruiting NCT06019832 - Analysis of Stem and Non-Stem Tibial Component N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT04513769 - Nutritious Eating With Soul at Rare Variety Cafe N/A
Withdrawn NCT03042897 - Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT05917873 - Metabolic Effects of Four-week Lactate-ketone Ester Supplementation N/A
Active, not recruiting NCT04353258 - Research Intervention to Support Healthy Eating and Exercise N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Completed NCT01870947 - Assisted Exercise in Obese Endometrial Cancer Patients N/A
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT05371496 - Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction Phase 2